Core Viewpoint - The company is actively exploring collaborations with major universities and hospitals to focus on the development of products and technologies in regenerative medicine for disease diagnosis and treatment [1] Group 1 - The company has stated that it will fulfill its information disclosure obligations in a timely manner if there are significant developments [1] - The subsidiary, Jiacheng Hospital, is actively pursuing the application for human assisted reproductive license qualifications [1] - The high barriers to assisted reproductive technology, along with the lengthy licensing application process and strict approval standards, create uncertainty regarding the company's future in the assisted reproductive business [1]